Monthly information on share capital and company voting rights

Cellectis (CLLS) reported a total of 100,732,781 shares in its capital as of October 31, 2026.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Cellectis (CLLS) reported a total of 100,732,781 shares in its capital as of October 31, 2026.

Total voting rights on the same date were 105,562,774. The monthly disclosure was made under Article 223-16 of the French financial markets authority’s General Regulation.

Key Figures

Shares in capital: 100,732,781 shares Voting rights: 105,562,774 voting rights

Shares in capital: 100,732,781 shares; As of October 31, 2026
Voting rights: 105,562,774 voting rights; As of October 31, 2026

Key Terms

isin code

1 terms

isin code financial

"Listing market: Euronext Growth ISIN code: FR0010425595"

An ISIN code is a unique identifier for a specific financial asset, like a stock or bond, similar to a product's barcode. It helps investors, traders, and banks quickly and accurately find and track that asset across different markets worldwide. This makes buying, selling, and managing investments more organized and reliable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

11/04/2026 - 04:30 PM EST

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Nov. 04, 2026 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
10/31/2026	100,732,781	105,562,774

For further information on Cellectis, please contact:

Media contacts:             
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com  
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93     
   
Investor Relations contact:          
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com  

Attachment